Trials / Recruiting
RecruitingNCT02804074
MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement
MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement (MASTER Study)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,240 (estimated)
- Sponsor
- Istituto Auxologico Italiano · Academic / Other
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
MASTER study is a 4-year prospective, randomized, open-label, blinded-endpoint study (PROBE) comparing 2 management strategies 1) office BP as a guide to treatment, or 2) 24-hour ABP as a guide to treatment. Study objectives are to investigate whether a management strategy based on out-of-office BP (Ambulatory BP monitoring) versus a management strategy based on office BP measurements is associated with differences in outcome, including cardiovascular and renal intermediate end points at one year; cardiovascular events at 4 years and changes in a number of blood pressure-related variables throughout the study. Patients will be followed-up during the first year focusing on changes in left ventricular mass index (LVMI, co-primary endpoint) and Urinary albumin excretion (UAE, albumin/creatinine ratio, co-primary end-point), and during the whole 48 month period for both changes in LVMI and UAE and events including all-cause mortality, CV morbidity and mortality, cerebral morbidity and mortality.A total of 1240 subjects will be recruited by 30 centers, taking into account a dropout rate of 15% (620 subjects per randomization arm).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Optimization of antihypertensive treatment based on office BP | Optimization of antihypertensive treatment based on office BP |
| OTHER | Optimization of antihypertensive treatment based on 24-hour ABPM | Optimization of antihypertensive treatment based on 24-hour ABPM |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2016-06-17
- Last updated
- 2026-03-30
Locations
2 sites across 2 countries: Italy, Venezuela
Source: ClinicalTrials.gov record NCT02804074. Inclusion in this directory is not an endorsement.